Ligand Pharmaceuticals Inc. financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2014-03-31 3 months ending 2013-12-31 9 months ending 2013-09-30 6 months ending 2013-06-30 3 months ending 2013-03-31
Revenue 15.96 14.74 34.24 21.23 11.65
Other Revenue, Total - - - - -
Total Revenue 15.96 14.74 34.24 21.23 11.65
Cost of Revenue, Total 2.45 1.32 4.42 1.88 0.66
Gross Profit 13.51 13.42 29.82 19.35 10.99
Selling/General/Admin. Expenses, Total 5.07 4.42 13.56 8.81 4.50
Research & Development 3.13 2.37 6.90 4.49 2.46
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) 0.20 0.20 0.84 0.61 0.09
Other Operating Expenses, Total - - - - -
Total Operating Expense 10.86 8.31 25.72 15.78 7.72
Operating Income 5.10 6.42 8.52 5.45 3.93
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net -2.70 -4.10 0.44 1.09 -1.65
Income Before Tax 2.15 2.01 7.20 5.17 1.37
Income After Tax 2.10 1.87 6.96 5.00 1.30
Minority Interest - - - - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items 2.10 1.87 6.96 5.00 1.30
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income 2.10 1.87 9.55 7.59 1.50
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items 2.10 1.87 6.96 5.00 1.30
Income Available to Common Incl. Extra Items 2.10 1.87 9.55 7.59 1.50
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment - - - - -
Diluted Weighted Average Shares 21.21 21.29 20.56 20.70 20.28
Diluted EPS Excluding Extraordinary Items 0.10 0.09 0.34 0.24 0.06
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS 0.11 0.10 0.38 0.27 0.07